Constellation Brands Total Cost of Revenue decreased by 6.8% to $968.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from $1.05B to $968.50M. Over 4 years (FY 2022 to FY 2026), Total Cost of Revenue shows relatively stable performance with a 1.9% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $907.20M | $1.14B | $1.09B | $969.90M | $1.11B | $1.33B | $1.21B | $1.04B | $1.26B | $1.39B | $1.20B | $1.10B | $1.26B | $1.41B | $1.18B | $1.05B | $1.25B | $1.17B | $1.04B | $968.50M |
| QoQ Change | — | +25.8% | -4.1% | -11.4% | +14.3% | +19.9% | -9.0% | -14.3% | +21.3% | +10.3% | -13.5% | -8.4% | +14.4% | +11.9% | -16.2% | -11.0% | +19.0% | -6.2% | -11.2% | -6.8% |
| YoY Change | — | — | — | — | +22.2% | +16.5% | +10.5% | +6.9% | +13.4% | +4.3% | -0.8% | +6.1% | +0.1% | +1.5% | -1.7% | -4.6% | -0.8% | -16.8% | -11.9% | -7.7% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 |
|---|---|---|---|
| Wine and Spirits | -$220.30M | -$224.70M | -$226.10M |
| Total | $1.26B | $1.41B | $1.18B |